PD-L1 maintains neutrophil extracellular traps release by inhibiting neutrophil autophagy in endotoxin-induced lung injury
Cheng‐long Zhu(Second Military Medical University), Jiafeng Wang(Zhejiang International Studies University), Yan Meng(Second Military Medical University), Jinjun Bian(Second Military Medical University), Xiaoming Deng(Second Military Medical University), Xiaojian Wan(Second Military Medical University), Yu Guo(Second Military Medical University), Qiang Liu(Sun Yat-sen University), Peng Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian Xie(Tongji University), Zhenzhen Zhao(Lanzhou University)
Cited by 47
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|434
Serum miR-146a and miR-223 as potential new biomarkers for sepsis
|Biochemical and Biophysical Research Communications|2010|361